Champions Oncology Inc.

NASDAQ: CSBR · Real-Time Price · USD
6.47
0.09 (1.41%)
At close: Jun 05, 2025, 3:59 PM
6.43
-0.62%
After-hours: Jun 05, 2025, 03:59 PM EDT

Champions Oncology Revenue Breakdown

Period Ending Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021 Apr 30, 2020 Apr 30, 2019
Personalized Oncology Services Revenue 18K 116K 49K 166K 790K 1.28M
Personalized Oncology Services Revenue Growth -84.48% +136.73% -70.48% -78.99% -38.14% n/a
Pharmacology Services Revenue 47.03M 50.71M 46.83M 39.47M 31.26M 25.48M
Pharmacology Services Revenue Growth -7.24% +8.27% +18.65% +26.27% +22.67% n/a
Product and Service, Other Revenue 3.1M n/a n/a n/a n/a n/a
Product and Service, Other Revenue Growth n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020 Apr 30, 2020 Jan 31, 2020 Oct 31, 2019 Jul 31, 2019 Apr 30, 2019 Jan 31, 2019 Oct 31, 2018 Jul 31, 2018 Apr 30, 2018 Jan 31, 2018 Oct 31, 2017 Jul 31, 2017 Apr 30, 2017 Jan 31, 2017 Oct 31, 2016 Jul 31, 2016 Apr 30, 2016 Jan 31, 2016 Oct 31, 2015 Jul 31, 2015 Apr 30, 2015 Jan 31, 2015
Selling, General, and Administrative Revenue 4.2M 3.64M 4.21M 4.54M 4.56M 4.39M 4.64M 4.59M 4.33M 4.23M 4.09M 4.38M 3.78M 3.62M 3.73M 3.3M 3.33M 2.82M 2.59M 3.58M 2.86M 2.11M 2.3M 2.29M 2.1M 1.77M 1.57M 1.6M 1.63M 1.5M 1.89M 2.46M 1.56M 1.74M 2.46M 1.87M 1.82M 2.53M 2.35M 2.34M 2.18M
Selling, General, and Administrative Revenue Growth +15.49% -13.46% -7.32% -0.50% +3.78% -5.20% +0.89% +6.12% +2.44% +3.35% -6.56% +15.92% +4.45% -3.03% +13.04% -0.90% +18.18% +8.73% -27.73% +25.18% +35.56% -8.01% +0.48% +8.71% +18.49% +12.78% -1.87% -1.72% +8.37% -20.45% -23.15% +57.62% -10.18% -29.28% +31.64% +2.64% -28.18% +8.01% +0.30% +7.29% n/a
Research and Development Revenue 1.72M 1.69M 1.45M 2.05M 2.19M 2.52M 2.79M 2.85M 3.2M 2.6M 2.89M 2.59M 2.18M 2.3M 2.3M 2.07M 1.88M 1.65M 1.6M 1.82M 1.39M 1.34M 1.3M 1.25M 1.27M 1.19M 1.09M 1.09M 1.04M 1.11M 1.12M 1.08M 998K 1.01M 1.21M 1.18M 999K 919K 1.1M 1.09M 1.09M
Research and Development Revenue Growth +1.78% +16.16% -29.04% -6.27% -13.08% -9.95% -2.10% -10.90% +22.96% -9.80% +11.47% +18.75% -5.13% -0.22% +11.30% +10.16% +13.88% +3.32% -12.20% +30.77% +3.73% +2.92% +4.41% -1.65% +6.37% +9.65% -0.55% +4.69% -6.28% -0.27% +3.90% +7.82% -0.99% -16.76% +2.98% +17.72% +8.71% -16.45% +1.10% -0.46% n/a
Sales and Marketing Revenue 1.81M 1.75M 1.68M 1.78M 1.8M 1.79M 1.7M 1.85M 1.76M 1.7M 1.69M 1.61M 1.55M 1.64M 1.57M 1.47M 1.49M 1.35M 1.21M 1.09M 1.31M 977K 870K 918K 879K 740K 518K 715K 627K 551K 683K 892K 726K 717K 925K 757K 779K 834K 1.03M 943K 1.09M
Sales and Marketing Revenue Growth +3.14% +4.29% -5.46% -1.17% +0.11% +5.84% -8.27% +5.00% +3.59% +0.47% +4.77% +4.26% -5.55% +4.19% +6.93% -1.34% +10.68% +11.59% +11.03% -16.76% +33.78% +12.30% -5.23% +4.44% +18.78% +42.86% -27.55% +14.04% +13.79% -19.33% -23.43% +22.87% +1.26% -22.49% +22.19% -2.82% -6.59% -18.95% +9.12% -13.80% n/a